Hardened Security
Processing of the data takes place in two steps, all in transit, in memory – as a first step, a copy of the data gets pushed to an end-to-end encrypted vault, managed by a leading industry provider – TrueVault.
Join.
SiteRx makes it easy and rewarding to help patients better access clinical trials.
Join the SiteRx Network and quickly start receiving effortless patient-trial matches from our industry-leading AI-based platform.
Practice.
Focus on what you do best – providing excellent care for your patients.
SiteRx's clinical trial matching platform removes the burdensome matching and administrative tasks which doctors report have kept them away from clinical trials.
Earn.
SiteRx compensates you for your time.
SiteRx not only automates matching and administrative tasks, it facilitates reimbursement for your time, as you help your patients access emerging therapies.
A recent Harris Interactive Survey of 6,000 patients found the vast majority were unaware that participating in a clinical trial was even an option. When properly informed about applicable clinical trials, 3 out of 4 patients would be receptive.
Let SiteRx do the heavy lifting – connecting your patients with appropriate clinical trials.
“SiteRx is an exciting presence in the neurology and clinical research landscape and is at the forefront of neurological innovation. SiteRx gives any neurologist the opportunity to join a growing community of thought leaders implementing it as a valuable tool for innovation in neurological care.”
Dr. Rudy Tanzi
Harvard University Professor of Neurology
The main drivers reported for clinical trial underutilization was not knowing how to enroll patients in a trial, administrative time burdens, little to no reimbursement, and trouble matching their patients' unique conditions to the best clinical trials and sites.
SiteRx’s free, HIPAA-Compliant software solves all of these problems.
“SiteRx is a true win-win for neurologists and their patients. It expands care options, while providing practices with a significant new revenue stream.”
Ira Goodman, M.D.
Board-certified Neurologist
